Forest Hypertension Drug Fails Trial
546150
Pharmaceutical firm Forest Laboratories Inc. on Tuesday said its hypertension drug lercanidipine failed to meet all the goals a mid-stage efficacy trial, delaying the drug&#39;s development timeline as the company considers alternatives.
413458
A blood pressure drug is ineffective in reducing cardiovascular deaths, research suggests.
350457
A major trail looking at drugs to treat high blood pressure has been stopped early because the results were so good.
682689
An HIV-positive pregnant woman enrolled in a NIH study examining the ability of the antiretroviral drug nevirapine to prevent mother-to-child HIV transmission died of liver failure that likely was caused by the drug.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
186524
A government-sponsored trial of Pfizer  Inc.'s PFE.N blockbuster arthritis drug Celebrex was halted  after patients taking the medicine had more than twice as many  heart attacks as patients taking a placebo, the company said on  Friday.
78912
A drug commonly used to treat high-blood pressure may slow or even halt the development of Parkinson's.
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
235475
The outcome of a clinical trial that failed to show Zetia has any benefits adds to concerns over the drug.
48658
Results from a crucial clinical trial showed that Northstar Neuroscienceâs brain-stimulating device failed to help stroke victims recover the use of their arms and hands.
225895
The recent failure of a potential blockbuster drug designed to increase so-called 'good cholesterol' raises important issues about diet and heart health. What is HDL, anyway?
44295
Forest Laboratories Inc.'s   Lexapro proved more effective than Eli Lilly and Co.'s   newer antidepressant Cymbalta in treating moderate to severe  depression in a small head-to-head study of the two medicines,  Forest said on Wednesday.
706499
Merck's promising AIDS vaccine candidate turned out to be an absolute failure in trials, but it may still pave the way for future success
646800
Gaithersburg-based GenVec has run into a problem with its top drug candidate, and investors have had an adverse reaction. GenVec says the US Food and Drug Administration has requested that clinical trials
422079
Forest Laboratories Inc.'s  Lexapro proved more effective than Eli Lilly and Co.'s  newer antidepressant Cymbalta in treating moderate to severe depression in a small head-to-head study of the two medicines, Forest said on Wednesday.
492768
[Health India]: London, Nov 6 : Swedish researchers at the Umea University Hospital have suggested that atenolol, one of the most widely prescribed beta-blockers for reducing blood pressure, may be ineffective in reducing heart attacks or death from
695084
A weight loss drug used by thousands of Britons has been rejected by US safety officials because of an increased risk of suicide.